The future of care and clinical research in Autism: updates from the Lancet Commission
Evdokia Anagnostou Bio:
Evdokia Anagnostou is a Child Neurologist and Professor of Pediatrics at the University of Toronto and Assistant Director of Holland Bloorview’s Research Institute. As a Senior Clinician Scientist, she co-leads of the Autism Research Centre (ARC) at Holland Bloorview and University of Toronto. She holds a Canada Research Chair in translational therapeutics in Autism Spectrum Disorder (ASD) and the Dr. Stuart D. Sims Chair in Autism at Holland Bloorview.
Dr. Anagnostou has received extensive international funding to understand the underlying biological differences associated with ASD and other neurodevelopmental differences, translate such understandings into potential novel interventions. She also has funding in health system innovation, stakeholder engagement, and in understanding the meaning and impact of ASD in marginalized populations. She serves on multiple government committees on improving diagnostic and intervention pathways, and several editorial boards and grant review panels.
She has also been recognized for her contributions to training young clinicians and scientists and for her commitment to women in STEM. She currently represents the region of America –North on the INSAR Global Senior Leaders committee.